Viewpoint: AI could guide us in understanding which cancer patients likely to benefit from expensive immunotherapy

olink x large v
Credit: Science

Over the last decade, significant advances in research, education, early detection methods and treatment have boosted cancer survival rates while new therapies continue to be developed. The recent introduction of cancer immunotherapies, in particular those based on immune checkpoint inhibitors, has created a paradigm shift in clinical oncology.

While tremendous progress has been made with immunotherapy modalities, today only a small percentage of patients are benefiting from such therapies.

[T]he high cost of immunotherapy ($30,000–300,000 per year for an individual patient) and the risk of developing immune-related adverse events place pressure on the health system to prescribe such therapies only to those patients who are most likely to benefit. However, robust methods to identify appropriate candidates for immunotherapy are still lacking.

Related article:  Viewpoint: YouTube, Facebook and Google should do more to stop spread of dangerous cancer quackery

As we enter the new decade, it is time to rethink the way we approach immunotherapy in order to benefit even more patients and their loved ones, while considering the financial realities on the ground. With the recent rise of artificial intelligence (AI) and machine learning tools to analyze complicated medical data, we now have the opportunity to profile patients earlier on in the immunotherapy treatment process to gain a new level of understanding that will ensure that precious time won’t be lost on a therapy that won’t have a positive impact.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend